Transaktionen anzeigen
Private Equity | Healthcare

DPC has been acquired by Innova/6 SCA SICAV-RAIF

Innova/6 SCA SICAV-RAIF has acquired stakes in three companies operating in the dental services market in Central and Eastern Europe – the Lithuanian chain Clinic DPC and Polish Dentaurus and Medicadent clinics. Innova, in cooperation with the founding doctors, will develop a leading, independent regional dental group.

Clinic DPC is the largest chain of dental clinics and the leading provider of dental implantation services in Lithuania. It operates 12 dental clinics in the country and one dental clinic in London, UK.

Innova/6 SCA SICAV-RAIF is an alternative investment fund of Innova Capital Group.

Oaklins’ team in Lithuania acted as financial advisor to the founder and owner of Clinic DPC.

Art der transaktion
BETEILIGTE PARTEIEN

Sprechen Sie mit dem Deal-Team

Mindaugas Matulaitis

Associate Partner
Vilnius, Litauen
Oaklins Baltics

Transaktionen

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Mehr erfahren
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Mehr erfahren
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Mehr erfahren